SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-17-009504
Filing Date
2017-05-17
Accepted
2017-05-17 17:11:27
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dffn20170516_s3.htm S-3 1336970
2 EXHIBIT 5.1 ex5-1.htm EX-5.1 23785
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 4227
4 a1.jpg GRAPHIC 2734
5 dffn20170516_s3img003.jpg GRAPHIC 10370
  Complete submission text file 0001437749-17-009504.txt   1384566
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-218062 | Film No.: 17852546
SIC: 2834 Pharmaceutical Preparations